Biofeedback for Adolescent Cannabis Use Disorder

Denver Health and Hospital Authority

Status and phase

Withdrawn

Phase 2

Phase 1

Conditions

Adolescent Cannabis Use Disorder

Treatments

Behavioral: Heart rate variability biofeedback

Behavioral: CBT

Study type

Interventional

Funder types

Other

Identifiers

NCT02059083

13-0412

Details and patient eligibility

About

The aims of this study are: 1) to estimate the effect size of HRV biofeedback for stress in adolescents undergoing cognitive behavioral therapy (CBT) for cannabis use disorder (primary outcome: Perceived Stress Scale) and 2) to estimate the effect size of HRV biofeedback for cannabis use in adolescents undergoing CBT for cannabis use disorder (primary outcome: number of days used cannabis in the past 30 days).

Sex

All

Ages

13 to 19 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

be between the ages of 13 and 19 years, with a parent or legal guardian available to complete parental assessments, if the participant is a minor
meet Diagnostic and Statistical Manual of Mental Disorders, 5th edition, (DSM-V) criteria for cannabis use disorder by clinical interview;
be medically healthy;
be willing to participate in the study intervention and assessments;
plan to live locally for at least 4 months;
be able to read English well enough to complete study questionnaires;
have self-reported cannabis use in the past 28 days;
have a Perceived Stress Scale score > 20.

Exclusion criteria

current or past psychosis;
bipolar I or II disorder;
the need to take psychotropic medications at any time during the study;
pregnancy;
psychiatric or substance use disorder that cannot be managed with outpatient care (e.g. alcohol withdrawal, severe major depressive disorder, significant suicidal ideation); and
medications known to affect HRV (e.g. albuterol, pseudoephedrine, beta adrenergic blockers).